Search Results for: Diabetes

3097 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ERBB3 and ODF2L erb-b2 receptor tyrosine kinase 3 outer dense fiber of sperm tails 2-like
ERBB3 and TNS4 erb-b2 receptor tyrosine kinase 3 tensin 4
ERBB3 and SOS1 erb-b2 receptor tyrosine kinase 3 son of sevenless homolog 1 (Drosophila)
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • SHC-mediated cascade
  • FCERI mediated MAPK activation
  • Platelet Aggregation (Plug Formation)
  • Signaling by EGFRvIII in Cancer
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Regulation of KIT signaling
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • SOS-mediated signalling
  • SHC-mediated signalling
  • Signaling by PDGF
  • DAP12 interactions
  • SHC-related events triggered by IGF1R
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • SHC1 events in ERBB4 signaling
  • Signalling to RAS
  • Downstream signal transduction
  • Signaling by Rho GTPases
  • Signaling by FGFR mutants
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • Signalling to ERKs
  • Axon guidance
  • IRS-mediated signalling
  • IGF1R signaling cascade
  • Rho GTPase cycle
  • IRS-related events triggered by IGF1R
  • EGFR Transactivation by Gastrin
  • GRB2 events in ERBB2 signaling
  • Activation of Rac
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • NCAM signaling for neurite out-growth
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cell death signalling via NRAGE, NRIF and NADE
  • SOS-mediated signalling
  • SHC-mediated signalling
  • Integrin alphaIIb beta3 signaling
  • p75 NTR receptor-mediated signalling
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • SHC-related events
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • SHC1 events in EGFR signaling
  • FRS2-mediated cascade
  • IRS-mediated signalling
  • Signal attenuation
  • NRAGE signals death through JNK
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Interleukin receptor SHC signaling
  • FCERI mediated Ca+2 mobilization
  • Constitutive Signaling by EGFRvIII
  • Signaling by Robo receptor
ERBB3 and NCK2 erb-b2 receptor tyrosine kinase 3 NCK adaptor protein 2
  • Signaling by PDGF
  • Ephrin signaling
  • Axon guidance
  • Activation of Rac
  • Signaling by VEGF
  • Downstream signal transduction
  • EPH-Ephrin signaling
  • Nephrin interactions
  • Signaling by Robo receptor
  • VEGFA-VEGFR2 Pathway
ERBB3 and HCK erb-b2 receptor tyrosine kinase 3 HCK proto-oncogene, Src family tyrosine kinase
  • HIV Infection
  • Host Interactions of HIV factors
  • Cytokine Signaling in Immune system
  • The role of Nef in HIV-1 replication and disease pathogenesis
  • Nef and signal transduction
  • Signaling by Interleukins
  • Regulation of signaling by CBL
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Interleukin-3, 5 and GM-CSF signaling
  • FCGR activation
  • Innate Immune System
  • 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • Phosphonotyrosine
  • Quercetin
  • Bosutinib
ERBB3 and HDAC6 erb-b2 receptor tyrosine kinase 3 histone deacetylase 6
  • HSF1 activation
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Organelle biogenesis and maintenance
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • Signaling by NOTCH
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by NOTCH1
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • FBXW7 Mutants and NOTCH1 in Cancer
ERBB3 and FLYWCH1 erb-b2 receptor tyrosine kinase 3 FLYWCH-type zinc finger 1
ERBB3 and RASA1 erb-b2 receptor tyrosine kinase 3 RAS p21 protein activator (GTPase activating protein) 1
  • Signaling by PDGF
  • EPHB-mediated forward signaling
  • Axon guidance
  • VEGFR2 mediated cell proliferation
  • Signaling by VEGF
  • Downstream signal transduction
  • EPH-Ephrin signaling
  • VEGFA-VEGFR2 Pathway
ERBB3 and GRB7 erb-b2 receptor tyrosine kinase 3 growth factor receptor-bound protein 7
  • Signaling by PDGF
  • Signaling by SCF-KIT
  • Signaling by ERBB2
  • Downstream signal transduction
  • GRB7 events in ERBB2 signaling
  • Tie2 Signaling
  • Cell surface interactions at the vascular wall
ERBB3 and RPN1 erb-b2 receptor tyrosine kinase 3 ribophorin I
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Diseases of glycosylation
  • Translation
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Post-translational protein modification
  • SRP-dependent cotranslational protein targeting to membrane
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Diseases associated with N-glycosylation of proteins
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
ERBB3 and PA2G4 erb-b2 receptor tyrosine kinase 3 proliferation-associated 2G4, 38kDa
ERBB3 and PIK3R1 erb-b2 receptor tyrosine kinase 3 phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by FGFR1 mutants
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • G alpha (q) signalling events
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • GP1b-IX-V activation signalling
  • Downstream signal transduction
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • Signaling by FGFR1 fusion mutants
  • Constitutive Signaling by EGFRvIII
  • PI3K Cascade
  • Isoproterenol
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
ERBB3 and PIK3R2 erb-b2 receptor tyrosine kinase 3 phosphoinositide-3-kinase, regulatory subunit 2 (beta)
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • G alpha (q) signalling events
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • Signaling by Rho GTPases
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Rho GTPase cycle
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • IRS-related events
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • PI3K Cascade
ERBB3 and PTK2 erb-b2 receptor tyrosine kinase 3 protein tyrosine kinase 2
  • Axon guidance
  • DCC mediated attractive signaling
  • Netrin mediated repulsion signals
  • Platelet Aggregation (Plug Formation)
  • VEGFA-VEGFR2 Pathway
  • EPHB-mediated forward signaling
  • EPHA-mediated growth cone collapse
  • Programmed Cell Death
  • EPH-Ephrin signaling
  • NCAM signaling for neurite out-growth
  • Netrin-1 signaling
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Regulation of actin dynamics for phagocytic cup formation
  • Innate Immune System
  • Apoptotic cleavage of cellular proteins
  • Apoptotic execution phase
  • p130Cas linkage to MAPK signaling for integrins
  • Integrin alphaIIb beta3 signaling
  • Signal regulatory protein (SIRP) family interactions
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • Signaling by VEGF
  • Platelet activation, signaling and aggregation
ERBB3 and PIK3R3 erb-b2 receptor tyrosine kinase 3 phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Interleukin-7 signaling
  • Phospholipid metabolism
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by ERBB2
  • G alpha (q) signalling events
  • Signaling by EGFR
  • Signaling by Interleukins
  • GPCR downstream signaling
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Costimulation by the CD28 family
  • PIP3 activates AKT signaling
  • Synthesis of PIPs at the plasma membrane
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • PI Metabolism
  • Innate Immune System
  • Signalling by NGF
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Signaling by FGFR
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
ERBB3 and DAPP1 erb-b2 receptor tyrosine kinase 3 dual adaptor of phosphotyrosine and 3-phosphoinositides
  • Signaling by the B Cell Receptor (BCR)
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Adaptive Immune System
  • Inositol 1,3,4,5-Tetrakisphosphate
ERBB3 and SHC1 erb-b2 receptor tyrosine kinase 3 SHC (Src homology 2 domain containing) transforming protein 1
  • Signaling by GPCR
  • Signaling by EGFRvIII in Cancer
  • Platelet Aggregation (Plug Formation)
  • SHC1 events in ERBB2 signaling
  • IRE1alpha activates chaperones
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • SHC-mediated signalling
  • G-protein beta:gamma signalling
  • SHC-related events triggered by IGF1R
  • Signaling by ERBB4
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by Interleukins
  • GPCR downstream signaling
  • SHC1 events in ERBB4 signaling
  • Signalling to RAS
  • Signaling by EGFR in Cancer
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Signalling to ERKs
  • IGF1R signaling cascade
  • XBP1(S) activates chaperone genes
  • G beta:gamma signalling through PI3Kgamma
  • Unfolded Protein Response (UPR)
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • SHC-mediated signalling
  • Integrin alphaIIb beta3 signaling
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Cytokine Signaling in Immune system
  • NGF signalling via TRKA from the plasma membrane
  • SHC-related events
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • SHC1 events in EGFR signaling
  • Signal attenuation
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Constitutive Signaling by EGFRvIII
  • SHC activation
ERBB3 and FER erb-b2 receptor tyrosine kinase 3 fer (fps/fes related) tyrosine kinase
  • Signaling by SCF-KIT
ERBB3 and GRB2 erb-b2 receptor tyrosine kinase 3 growth factor receptor-bound protein 2
  • Pegademase bovine
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
ERBB3 and NRG2 erb-b2 receptor tyrosine kinase 3 neuregulin 2
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • SHC1 events in ERBB2 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • Signalling by NGF
  • DAP12 interactions
  • GAB1 signalosome
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by ERBB4
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • Nuclear signaling by ERBB4
  • SHC1 events in ERBB4 signaling
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System

Page 13 out of 155 pages